Clover Health Investments Past Earnings Performance
Past criteria checks 0/6
Clover Health Investments's earnings have been declining at an average annual rate of -7.8%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 41.6% per year.
Key information
-7.8%
Earnings growth rate
49.8%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 41.6% |
| Return on equity | -74.5% |
| Net Margin | -10.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Clover Set To Report Earnings Tonight: Levels To Watch
May 09Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week
Mar 04Good News From Clover Health
Feb 25Clover Health Is Now Undervalued, But Gains Not Guaranteed
Jan 24Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out
Dec 03Why Clover Health Investments (NASDAQ:CLOV) has Time to Develop a Superior Product
Oct 21Clover Health: Dilution Fears
Sep 24Clover Health: The Product Is Good, The Balance Sheet Is Not
Sep 02Clover Health Investments, Corp. (NASDAQ:CLOV) Lacks Institutional Ownership, but has High Growth and Co-Founders with Skin in the Game
Aug 26Revenue & Expenses BreakdownBeta
How Clover Health Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,036 | -213 | 445 | 0 |
| 30 Sep 23 | 2,440 | -226 | 459 | 0 |
| 30 Jun 23 | 2,841 | -260 | 475 | 0 |
| 31 Mar 23 | 3,195 | -336 | 489 | 0 |
| 31 Dec 22 | 3,579 | -340 | 487 | 0 |
| 30 Sep 22 | 3,041 | -443 | 476 | 0 |
| 30 Jun 22 | 2,564 | -402 | 478 | 0 |
| 31 Mar 22 | 2,075 | -615 | 468 | 0 |
| 31 Dec 21 | 1,361 | -588 | 446 | 0 |
| 30 Sep 21 | 1,158 | -527 | 387 | 0 |
| 30 Jun 21 | 922 | -487 | 314 | 0 |
| 31 Mar 21 | 721 | -160 | 247 | 0 |
| 31 Dec 20 | 690 | -136 | 192 | 0 |
| 30 Sep 20 | 624 | -89 | 186 | 0 |
| 30 Jun 20 | 572 | -145 | 177 | 0 |
| 31 Mar 20 | 507 | -272 | 185 | 0 |
| 31 Dec 19 | 455 | -364 | 187 | 0 |
| 31 Dec 18 | 281 | -202 | 187 | 0 |
Quality Earnings: CLOV is currently unprofitable.
Growing Profit Margin: CLOV is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLOV is unprofitable, and losses have increased over the past 5 years at a rate of 7.8% per year.
Accelerating Growth: Unable to compare CLOV's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLOV is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (7.1%).
Return on Equity
High ROE: CLOV has a negative Return on Equity (-74.5%), as it is currently unprofitable.